Asploro Journal of Biomedical and Clinical Case Reports

Asploro Journal of Biomedical and Clinical Case Reports

Hiroshi Bando^1,2ID*, Noboru Iwatsuki¹, Masaki Okada¹, Tomoya Ogawa¹, Kazuki Sakamoto^1
1Sakamoto Hospital, Higashi Kagawa city, Kagawa, Japan
²Tokushima University/Medical research, Tokushima, Japan

Corresponding Author: Hiroshi BANDO, MD, PhD, FACP ^{ORCID iD}
Address: Tokushima University /Medical Research, Nakashowa 1-61, Tokushima 770-0943, Japan.
Received date: 30 May 2023; Accepted date: 17 June 2023; Published date: 24 June 2023

Citation: Bando H, Iwatsuki N, Okada M, Ogawa T, Sakamoto K. Maintained Renal Function by Blood Pressure Control in Patient with Diabetic Kidney Disease (DKD). Asp Biomed Clin Case Rep. 2023 Jun 24;6(2):130-37.

Copyright © 2023 Bando H, Iwatsuki N, Okada M, Ogawa T, Sakamoto K. This is an open-access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium provided the original work is properly cited.

Keywords: Type 2 Diabetes, Anti-Hypertensive Agents, Low Carbohydrate Diet, Chronic Kidney Disease Epidemiology Collaboration, Estimated Glomerular Filtration Rate

Abbreviations: T2D: Type 2 Diabetes, AHAs: Anti-Hypertensive Agents, LCD: Low Carbohydrate Diet, CKD-EPI: Chronic Kidney Disease Epidemiology Collaboration, eGFR: Estimated Glomerular Filtration Rate

Abstract

The case involves a 74-year-old male with type 2 diabetes (T2D), hypertension, dyslipidemia, and diabetic kidney disease (DKD) at nephropathy stage G3b. He has been receiving treatment with insulin and anti-hypertensive agents (AHAs). In July 2021, his HbA1c was elevated to 7.9%. As a result, the extent of his low carbohydrate diet (LCD) was increased, and insulin doses were raised. The AHAs were changed from Olmesartan to Valsartan/Amlodipine, and Irbesartan/Amlodipine until 2023. By January 2023, his HbA1c had decreased to 6.8%, and his eGFR (CKD-EPI) had remained stable at 34-48 mL/min/1.73/m² for 4 years. A recent study demonstrated clinical improvement in renal function through continuous LCD in patients with DKD.